je.st
news
A.P. Pharma Receives FDA Complete Response Letter For APF530
2013-03-28 08:00:00| dairynetwork Home Page
A.P. Pharma, Inc., a specialty pharmaceutical company, recently announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Tags: complete
response
letter
receives
Category:Agriculture and Forestry